Carregant...

Cerebrospinal fluid biomarkers of Alzheimer’s disease in cognitively healthy elderly

Numerous studies have shown that Alzheimer’s Disease (AD) pathology begins before the onset of clinical symptoms. Because therapies are likely to be more effective if they are implemented early in the disease progression, it is necessary to identify reliable biomarkers to detect AD pathology in the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Randall, Catherine, Mosconi, Lisa, de Leon, Mony, Glodzik, Lidia
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3904672/
https://ncbi.nlm.nih.gov/pubmed/23747874
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!